CAR T-Cell Therapy Market to Explode 1200%+ To $35.9 Bn, Forecast To 2032 | Business Leaders, Analysts & Strategic Teams

The CAR T-Cell Therapy industry in North America held a significant share of over 62.1% in 2022. Region-wise, North America held the largest market share.

WILMINGTON, DE, UNITED STATES, July 17, 2025 /EINPresswire.com/ -- The growth of the CAR T-cell therapy market is driven by increase in prevalence of leukemia across the globe, increase in investment for research and development of the new CAR T-cell therapy, and high effectivity of CAR T-cell therapy over other conventional drugs for cancer treatment. The CAR T-cell therapy market size was valued at $2.6 billion in 2022 and is estimated to reach $35.9 billion by 2032, exhibiting a CAGR of 28.5% from 2023 to 2032.

► Don't Miss Out “Download Your Exclusive Sample PDF Report” Now:
https://www.alliedmarketresearch.com/request-sample/17358

The growth of the CAR T-cell therapy market is driven by increase in prevalence of leukemia across the globe, increase in investment for research and development of the new CAR T-cell therapy, and high effectivity of CAR T-cell therapy over other conventional drugs for cancer treatment. According to the Leukemia Research Foundation, an estimate of 6,660 new cases of acute lymphoblastic leukemia were diagnosed in 2022. This rise in cases of leukemia has propelled the demand for CAR T-cell therapy, which drives the market growth.

Major market players covered in the report, such as -

• Autolus Therapeutics,

• Bluebird bio, Inc.,

• Bristol-Myers Squibb,

• Caribou Biosciences, Inc.,

• Cartesian Therapeutics, Inc.,

• Celgene Corporation,

• Cellectis,

• Celyad Oncology,

• Gilead Sciences, Inc. (Kite Pharma Inc.),

• Intellia Therapeutics,

• Juno Therapeutics, Inc.,

• Merck & Co., Inc.,

• Miltenyi Biotech,

• Novartis AG,

• Pfizer, Inc.,

• Sorrento Therapeutics, Inc.

★ Procure Complete Report [ 219 Pages PDF with Insights, Charts, Tables, and Figures ] @
https://www.alliedmarketresearch.com/car-t-cell-therapy-market/purchase-options

Key Benefits for Stakeholders -

• The report provides quantitative analysis of market segments, current trends, strategies and potential of CAR T-Cell therapy Market research to identify potential CAR T-Cell therapy Market opportunities in genetics.
• In-depth analysis of this sector helps identify current market opportunities.
• Market analysis and information related to key drivers, restraints and opportunities are provided.
• Porter's Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
• The largest countries in each region are listed according to their contribution to the global market.
• Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
• The report includes regional and global CAR T-Cell therapy Market analysis, key players, market segments, application areas and Market growth strategies.

The potential benefits of CAR T-cell therapy are significant. Unlike chemotherapy and radiation therapy, which can have significant side effects, CAR T-cell therapy is a targeted therapy that only attacks cancer cells, leaving healthy cells unharmed. Additionally, CAR T-cell therapy has shown to have long-lasting effects, with some patients remaining cancer-free years after treatment.

However, there are also potential drawbacks to CAR T-cell therapy. One major concern is the cost, as the therapy can be expensive and may not be accessible to everyone. Additionally, CAR T-cell therapy can have serious side effects, such as cytokine release syndrome (CRS), which occurs when the infused T-cells release large amounts of cytokines, causing fever, fatigue, and other symptoms.

In conclusion, CAR T-cell therapy is a promising new cancer treatment that has the potential to revolutionize cancer care. While it is not without its drawbacks, its targeted approach and long-lasting effects make it an exciting development in the fight against cancer. As research continues, it is likely that CAR T-cell therapy will become a more common and effective treatment option for cancer patients in the future.

👉 For Purchase Inquiry of Report:
https://www.alliedmarketresearch.com/purchase-enquiry/17358

Frequently Asked Questions?

Q1. What is the market value of CAR T-Cell Therapy Market in 2032?

Q2. What would be forecast period in the market report?

Q3. Which is base year calculated in the CAR T-Cell Therapy Market report?

Q4. Which are the top companies holding the market share in CAR T-Cell Therapy Market?

Q5. What factors drive the growth of CAR T-Cell Therapy Market?

Q6. What is CAR T-Cell Therapy?

►►► Exclusive Related Reports with “Market Insights” ►►►

Intraocular Lens Market - https://www.alliedmarketresearch.com/intraocular-lens-market

Cosmetic Surgery Market - https://www.alliedmarketresearch.com/cosmetic-surgery-market-A16492

Nurse Call Systems Market - https://www.alliedmarketresearch.com/nurse-call-systems-market

HIV Drugs Market - https://www.alliedmarketresearch.com/hiv-drugs-market

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

► Read More Exclusive Articles with Detailed Insights -

https://medium.com/@Kanikagupte
https://healthcarelatestupdate.blogspot.com/
https://www.tumblr.com/blog/healthcarenewsupdates

David Correa
Allied Market Research
+ + 1 800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.